DNAH11 Gene Primary ciliary dyskinesia type 7 Genetic Test
At DNA Labs UAE, we offer the DNAH11 Gene Primary ciliary dyskinesia type 7 Genetic Test for individuals who suspect they may have this genetic disorder. This test is designed to analyze the DNAH11 gene, which is associated with primary ciliary dyskinesia type 7 (PCD7).
Test Components
The DNAH11 Gene Primary ciliary dyskinesia type 7 Genetic Test includes the following components:
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Ear Nose Throat Disorders
- Doctor: ENT Doctor
- Test Department: Genetics
Pre Test Information
Prior to undergoing the DNAH11 Gene Primary ciliary dyskinesia type 7 Genetic Test, it is important to provide the clinical history of the patient. In this case, the patient is going for the GJB2 Gene Deafness with keratopachydermia and constrictions of fingers and toes NGS Genetic DNA Test. Additionally, a Genetic Counselling session is required to draw a pedigree chart of family members affected with GJB2 Gene Deafness with keratopachydermia and constrictions of fingers and toes NGS Genetic DNA Test gene GJB19.
Test Details
The DNAH11 gene is associated with a genetic disorder called primary ciliary dyskinesia type 7 (PCD7). PCD is a rare genetic condition characterized by abnormal movement of cilia, which are hair-like structures that line the respiratory tract, sinuses, and other organs.
NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that allows for the simultaneous analysis of multiple genes. In the case of PCD7, NGS genetic testing can identify mutations or variations in the DNAH11 gene that may be responsible for the development of the disorder.
This type of genetic testing can help in the diagnosis of PCD7, as well as provide information about the specific genetic variants present in an individual. This information can be useful for understanding the underlying cause of the condition, predicting disease progression, and informing treatment options.
Test Name | DNAH11 Gene Primary ciliary dyskinesia type 7 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Ear Nose Throat Disorders |
Doctor | ENT Doctor |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for GJB2 Gene Deafness with keratopachydermia and constrictions of fingers and toes NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with GJB2 Gene Deafness with keratopachydermia and constrictions of fingers and toes NGS Genetic DNA Test gene GJB19 |
Test Details |
The DNAH11 gene is associated with a genetic disorder called primary ciliary dyskinesia type 7 (PCD7). PCD is a rare genetic condition characterized by abnormal movement of cilia, which are hair-like structures that line the respiratory tract, sinuses, and other organs. NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that allows for the simultaneous analysis of multiple genes. In the case of PCD7, NGS genetic testing can identify mutations or variations in the DNAH11 gene that may be responsible for the development of the disorder. This type of genetic testing can help in the diagnosis of PCD7, as well as provide information about the specific genetic variants present in an individual. This information can be useful for understanding the underlying cause of the condition, predicting disease progression, and informing treatment options. |